CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study is being done to answer the following question: What are the effects of a new drug or drugs on ovarian cancer? The pre-s...
Phase 2
Montreal, Quebec, Canada and 6 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Montreal, Quebec, Canada and 125 other locations
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Montreal, Quebec, Canada and 213 other locations
be tested together for the first time in patients with recurrent ovarian, fallopian tube, or peritoneal cancer to determine the saf...
Phase 1, Phase 2
Montréal, Quebec, Canada and 8 other locations
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
Montréal, Canada and 46 other locations
positive, recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer following 1 pri...
Phase 2
Montréal, Quebec, Canada and 70 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Montreal, Quebec, Canada and 176 other locations
A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer....
Phase 2
Montreal, Quebec, Canada and 14 other locations
While ASA is not a cancer medication, research suggests that taking ASA reduces the probability of getting many types of cancer bec ...
Phase 2
Montreal, Quebec, Canada and 16 other locations
A Phase 2/3 study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer...
Phase 2, Phase 3
Montréal, Quebec, Canada and 38 other locations
Clinical trials
Research sites
Resources
Legal